ADAMTS-13 Activity Assay

Coagulation


Description

ADAMTS-13 (a disintegrin-like and metalloproteinase with thrombospondin type 1 motif 13) is an enzyme (vWF-cleaving protease) that specifically cleaves unusually large vWF multimers (ULvWF) which induce platelet thrombus formation under high shear stress. If the activity is lowered, ULvWF may accumulate within the blood causing thrombosis due to platelet aggregation, which in turn may lead to Thrombotic Thrombocytopenic Purpura (TTP).


Sample Type

Plasma (Citrate 2.7ml Blue) x 2


Reference Range

52-149 IU/dL


Turnaround Time

Within 1 day


Testing Frequency

On demand


External Notes

See ADAMTS-13 Activity and Antibody Assays Referral form


Patient Preparation

Preparation No special requirements.


References

Hubbard AR et al. Establishment of the WHO 1st International Standard ADAMTS13, plasma (12/252): communication from the SSC of the ISTH. J Thromb Haemost. 2015 Jun;13(6):1151-3.


See Also

ADAMTS-13 ANTIBODY ASSAY

Please note: the above information is subject to change and we endeavour to keep this website up to date wherever necessary.

Your contact for this test

team

Rebekah Fretwell BSc (Hons) Medicine and Pharmacology, MSc Pathology

Senior Biomedical Scientist and ADAMTS-13 Section Lead - Coagulation

You are enquiring about

ADAMTS-13 Activity Assay